We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Self-Administered HPV Test Helps Screen for Cervical Cancer

By LabMedica International staff writers
Posted on 09 Feb 2012
Patient-collected specimens for human papillomavirus (HPV) DNA testing detected precancerous cervical lesions with an accuracy comparable to that of liquid-based cytology (LBC) and visual inspection with acetic acid, according to a new study.

Researchers at Peking Union Medical College (PUMC; Beijing, China), Mount Sinai School of Medicine (New York, NY, USA), and other institutions worldwide reviewed patient data from five population-based cervical cancer–screening studies in China. More...
In all, 13,140 participants underwent Self-HPV testing, physician-collected cervical specimens for HPV testing, LBC, and visual inspection with acetic acid (VIA). Screen-positive women had a subsequent colposcopy and confirmatory biopsy. The researchers than analyzed the accuracies of pooled Self-HPV testing, Physician-HPV testing, VIA, and LBC to detect biopsy-confirmed cervical intraepithelial neoplasia grade 2 or more severe (CIN2+), and CIN3+.

The results showed that 3.9% of the women were diagnosed as CIN2+, 2.1% as CIN3+, and 0.3% with cervical cancer. Self-HPV testing had 86.2% sensitivity and 80.7% specificity for detecting CIN2+, and 86.1% sensitivity and 79.5% specificity for detecting CIN3+. VIA had statistically significantly lower sensitivity for detecting CIN2+ and CIN3+, and higher specificity for detecting CIN2+ and CIN3+ than Self-HPV testing, while LBC had lower sensitivity for detecting CIN2+, similar sensitivity for detecting CIN3+, and higher specificity for detecting CIN2+ and CIN3+ than Self-HPV testing. Physician-HPV testing, on the other hand, was more sensitive for detecting CIN2+ and CIN3+, but similarly specific for detecting CIN2+ and CIN3+ than Self-HPV testing.

“Although it is not specific enough to be a stand-alone test, self-HPV testing provides sensitive results without pelvic exams, medical professionals, or healthcare facilities and thus has the potential to serve as a primary cervical cancer screening method for women, regardless of their geographic location or access to healthcare,” concluded lead author You-Lin Qiao, MD, PhD, of PUMC. “Limited resources can then be focused on the clinical follow up of the smaller percentage of women who tested positive.”

One-seventh of all cervical cancers worldwide occur in China, which lacks a national screening program. Self-collected cervicovaginal specimens tested for HPV DNA could therefore effectively serve as a primary cervical cancer screening method in China and other low-resource settings.

Related Links:
Peking Union Medical College
Mount Sinai School of Medicine


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.